title: Peripheral purinergic receptor modulation influences the trigeminal ganglia nitroxidergic system in an experimental murine model of inflammatory orofacial pain.
abstract: ATP plays an important role as an endogenous pain mediator generating and/or modulating pain signaling from the periphery to the central nervous system. The aim of this study was to analyze the role of peripheral purinergic receptors in modulation of the nitroxidergic system at a trigeminal ganglia level by monitoring changes in nitric oxide synthase isoforms. We also evaluated Fos-positive neurons in brainstem (spinal trigeminal nucleus) and pain-related behavior. We found that local administration of the P2 purinergic receptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS) decreased face-rubbing activity, nitric oxide synthase isoform expression in trigeminal ganglia, and Fos expression in spinal trigeminal nucleus after subcutaneous injection of formalin. These results suggest a role for peripheral P2 purinergic receptors in orofacial pain transmission through modulation of the nitroxidergic system. .
authors.affiliation: Division of Human Anatomy, Department of Biomedical Sciences and Biotechnologies, Brescia University, 25123 Brescia, Italy.
authors.forename: Elisa
authors.initials: E
authors.lastname: Borsani
authors.forename: Roberta
authors.initials: R
authors.lastname: Albertini
authors.forename: Mauro
authors.initials: M
authors.lastname: Labanca
authors.forename: Claudio
authors.initials: C
authors.lastname: Lonati
authors.forename: Rita
authors.initials: R
authors.lastname: Rezzani
authors.forename: Luigi F
authors.initials: LF
authors.lastname: Rodella
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D005157:Facial Pain / Q000378:metabolism* / Q000473:pathology; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D018836:Inflammation Mediators / Q000378:metabolism / Q000502:physiology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D026602:Nitrergic Neurons / Q000378:metabolism* / Q000473:pathology; D009569:Nitric Oxide / Q000096:biosynthesis / Q000502:physiology*; D009619:Nociceptors / Q000378:metabolism*; D058476:Receptors, Purinergic P2X2 / Q000502:physiology*; D058477:Receptors, Purinergic P2X3 / Q000502:physiology*; D012668:Trigeminal Ganglion / Q000378:metabolism* / Q000473:pathology
chemical_list: D018836:Inflammation Mediators; C546402:P2rx2 protein, mouse; C546409:P2rx3 protein, mouse; D058476:Receptors, Purinergic P2X2; D058477:Receptors, Purinergic P2X3; D009569:Nitric Oxide